ReviewCurrent sleep medicine reports2026
From Better Sleep to Improved Mood: A Review of the Biopsychosocial Pathways for Cognitive Behavioral Therapy for Insomnia's Antidepressant Effects.
Review in Current sleep medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose of Review: Recent research supports that Cognitive Behavioral Therapy for Insomnia (CBT-I) improves both insomnia and depression symptoms. The primary purpose of the current review was to summarize potential mechanistic pathways linking insomnia and depression while evaluating how improvements in sleep via CBT-I may lead to reduced depressive symptoms. Recent Findings: The current literature supports that there are several potential biological, behavioral, and cognitive-affective mechanisms, including improved hypothalamic-pituitary-adrenal (HPA) axis and inflammatory functioning, behavioral activation, and emotion regulation, that may explain the antidepressant effects of CBT-I. Summary: Critically evaluating the potential mechanisms by which CBT-I improves depression (e.g., HPA-axis, inflammatory, behavioral, and emotional processes) will inform future efforts to enhance the overall effectiveness of CBT-I in patients with comorbid depression. Specifically, it will identify specific mechanisms that can be the focus of more targeted interventions or strategies to streamline CBT-I in patients with depression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.